---
figid: PMC3156249__nihms-298052-f0001
figlink: /pmc/articles/PMC3156249/figure/F1/
number: F1
caption: Activation of the Rb pathway during senescence restricts B-sMyb action at
  multiple levels. At the DNA level, activating E2F complexes at the B-Myb promoter
  are replaced by inhibitory complexes between E2F4 and p107 and p130. At the RNA
  level, elevated levels of miR-29 and miR-30 base-pair to the 3′UTR of B-Myb mRNA,
  reducing its abundance. At the protein level, reduced expression of B-Myb-responsive
  genes lowers cyclin/cdk activity and the extent of activating phosphorylation of
  B-Myb. In addition, ubiquitylation and degradation of B-Myb, as well as preferential
  association with co-repressors, may further inhibit its ability to activate target
  genes.
pmcid: PMC3156249
papertitle: B-Myb, Cancer, Senescence, and MicroRNAs.
reftext: Ivan Martinez, et al. Cancer Res. ;71(16):5370-5373.
pmc_ranked_result_index: '148118'
pathway_score: 0.9676481
filename: nihms-298052-f0001.jpg
figtitle: B-Myb, Cancer, Senescence, and MicroRNAs
year: ''
organisms:
- Mus musculus
- Human papillomavirus
- Avian retroviruses
- Homo sapiens
ndex: 5084968a-dea8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3156249__nihms-298052-f0001.html
  '@type': Dataset
  description: Activation of the Rb pathway during senescence restricts B-sMyb action
    at multiple levels. At the DNA level, activating E2F complexes at the B-Myb promoter
    are replaced by inhibitory complexes between E2F4 and p107 and p130. At the RNA
    level, elevated levels of miR-29 and miR-30 base-pair to the 3′UTR of B-Myb mRNA,
    reducing its abundance. At the protein level, reduced expression of B-Myb-responsive
    genes lowers cyclin/cdk activity and the extent of activating phosphorylation
    of B-Myb. In addition, ubiquitylation and degradation of B-Myb, as well as preferential
    association with co-repressors, may further inhibit its ability to activate target
    genes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - E2F7
  - E2F2
  - MYBL2
  - RBL1
  - E2F8
  - CDK2
  - E2F4
  - E2F1
  - SKP2
  - CCNA1
  - E2F6
  - CCNA2
  - E2F5
  - E2F3
genes:
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: B-Myb
  symbol: B-MYB
  source: hgnc_alias_symbol
  hgnc_symbol: MYBL2
  entrez: '4605'
- word: p107/p130
  symbol: p107
  source: hgnc_alias_symbol
  hgnc_symbol: RBL1
  entrez: '5933'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: A/Cdk2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: E2F4
  symbol: E2F4
  source: hgnc_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: SKP2
  symbol: SKP2
  source: hgnc_symbol
  hgnc_symbol: SKP2
  entrez: '6502'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: CyclinA/Cdk2
  symbol: Cyclin_A
  source: bioentities_symbol
  hgnc_symbol: CCNA1
  entrez: '8900'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: CyclinA/Cdk2
  symbol: Cyclin_A
  source: bioentities_symbol
  hgnc_symbol: CCNA2
  entrez: '890'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
chemicals: []
diseases: []
figid_alias: PMC3156249__F1
redirect_from: /figures/PMC3156249__F1
figtype: Figure
---
